$ALXN ALEXION PHARMACEUTICALS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in ALEXION PHARMACEUTICALS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
ALEXION PHARMACEUTICALS, INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ALEXION PHARMACEUTICALS INC | 10% Owner | 1,109,910 | 141,757,705 | Jul 28 2020 | |||
| ANDERSON DAVID J | EVP, Chief Financial Officer | 8,689 | 1,109,759 | Dec 13 2016 | |||
| BAKER BROS ADVISORS LLC | Director | 997,764 | 127,434,418 | May 18 2020 | |||
| BAKER FELIX | Director | 6,104,562 | 779,674,659 | May 13 2016 | |||
| Bazarko Daniel | SVP, Controller, CAO | 38,499 | 4,917,092 | Mar 02 2021 | |||
| BELL LEONARD | Director | 391,910 | 50,054,745 | Mar 01 2017 | |||
| BELL LEONARD | CEO | 944,308 | 120,607,018 | Feb 12 2015 | |||
| BOESS CARSTEN | Vice President & CFO | 0 | 0 | Jun 29 2005 | |||
| BOWDISH KATHERINE S | Senior Vice President | 40,196 | 5,133,833 | Jun 15 2005 | |||
| Brennan David R | Director | 19,499 | 2,490,412 | May 24 2021 | |||
| Brennan David R | Director | 1,268 | 161,949 | Dec 16 2014 | |||
| BURNS M MICHELE | Director | 4,353 | 555,965 | May 12 2017 | |||
| BURNS M MICHELE | Director | 788 | 100,643 | Dec 08 2014 | |||
| Carino Tanisha | EVP & CCAO | 17,632 | 2,251,959 | Dec 04 2020 | |||
| Carmichael Clare | EVP, Chief HR Officer | 33,980 | 4,339,926 | Mar 01 2017 | |||
| Carmichael Clare | EVP, Chief HR Officer | 21,670 | 2,767,692 | Feb 12 2015 | |||
| Carmichael Clare | SVP, Chief HR Officer | 8,000 | 1,021,760 | Feb 06 2012 | |||
| Chiniara Ellen | EVP & Chief Legal Officer | 62,917 | 8,035,759 | Dec 18 2020 | |||
| Clancy Paul J | EVP, Chief Financial Officer | 90,447 | 11,551,891 | Jul 15 2019 | |||
| Coissac Patrice | SVP & Pres. ALXN Pharma Int'l | 1,118 | 142,791 | Nov 02 2012 | |||
| COUGHLIN CHRISTOPHER J | Director | 36,882 | 4,710,569 | May 18 2020 | |||
| COUGHLIN CHRISTOPHER J | Director | 768 | 98,089 | Jul 24 2014 | |||
| DUBIN THOMAS I H | SVP & Chief Legal Officer | 65,705 | 8,391,843 | Aug 27 2012 | |||
| Dunsire Deborah | Director | 11,193 | 1,429,570 | May 18 2020 | |||
| Franchini Indrani Lall | EVP, Chief Compliance Officer | 66,183 | 8,452,893 | Dec 18 2020 | |||
| FRIEDMAN PAUL A | Director | 10,345 | 1,321,263 | May 18 2020 | |||
| Goff Brian | EVP & Chief Commercial Officer | 88,696 | 11,328,253 | Dec 18 2020 | |||
| Hallal David | CEO | 189,266 | 24,173,054 | Aug 10 2016 | |||
| HANTSON LUDWIG | CEO | 349,166 | 44,595,482 | Apr 01 2021 | |||
| Islam Saqib | EVP, Chief Strat & Port. Off. | 43,799 | 5,594,008 | Mar 01 2016 | |||
| JACKSON JERRY T | Director | 0 | 0 | Dec 17 2003 | |||
| JACKSON JERRY T | 1,300 | 166,036 | Mar 10 2005 | ||||
| KEISER DAVID W | Director | 149,546 | 19,100,015 | Jun 03 2009 | |||
| KELLER WILLIAM R | Director | 7,276 | 929,291 | Dec 08 2014 | |||
| LAW ANNE-MARIE | EVP, Chief Experience Officer | 41,423 | 5,290,546 | Jun 09 2020 | |||
| LINK MAX | Director | 96,103 | 12,274,275 | Feb 06 2012 | |||
| LINK MAX | Director | 57,657 | 7,363,952 | May 07 2007 | |||
| LINK MAX | Director | 0 | 0 | Dec 13 2005 | |||
| LINK MAX | Director | 169,781 | 21,684,429 | Aug 28 2012 | |||
| LINK MAX | Director | 174,575 | 22,296,719 | Jan 28 2009 | |||
| LINK MAX | Director | 137,540 | 17,566,609 | May 25 2010 | |||
| LINK MAX | Director | 89,781 | 11,466,829 | Aug 15 2012 | |||
| LINK MAX | Director | 154,575 | 19,742,319 | Sep 14 2009 | |||
| LINK MAX | Director | 59,469 | 7,595,381 | May 07 2014 | |||
| LUKE BARRY P | VP, Finance & Administration | 24,800 | 3,167,456 | Jul 18 2005 | |||
| MACKAY MARTIN | EVP & Global Head of R&D | 38,883 | 4,966,137 | Mar 01 2017 | |||
| MACKAY MARTIN | EVP & Global Head of R&D | 32,219 | 4,115,011 | Feb 12 2015 | |||
| MADRI JOSEPH A | Director | 179,217 | 22,889,595 | Mar 13 2014 | |||
| MATHIS LARRY | Director | 1,000 | 127,720 | Dec 14 2004 | |||
| MATHIS LARRY | Director | 11,115 | 1,419,608 | May 31 2012 | |||
| MATHIS LARRY | Director | 29,456 | 3,762,120 | May 01 2013 | |||
| MATHIS LARRY | Director | 30,351 | 3,876,430 | Mar 04 2014 | |||
| Miller Edward | SVP, Chief Compliance Officer | 15,214 | 1,943,132 | Mar 01 2017 | |||
| MOJCIK CHRISTOPHER F | SVP Clinical Development | 14,152 | 1,807,493 | May 31 2007 | |||
| Mollen John T | Director | 12,701 | 1,622,172 | May 18 2020 | |||
| Mollen John T | Director | 830 | 106,008 | Jul 24 2014 | |||
| Monnet Dominique | SVP, Chief Marketing Officer | 8,787 | 1,122,276 | May 22 2015 | |||
| Moriarty John B | EVP & General Counsel | 71,400 | 9,119,208 | Feb 08 2018 | |||
| MOTOLA NANCY | Sr. VP Regulatory & Quality | 3,000 | 383,160 | Mar 11 2005 | |||
| Nader Francois | Director | 10,345 | 1,321,263 | May 18 2020 | |||
| NORBY R DOUGLAS | Director | 4,906 | 626,594 | May 12 2017 | |||
| NORBY R DOUGLAS | Director | 38,673 | 4,939,316 | Dec 12 2012 | |||
| NORBY R DOUGLAS | Director | 11,089 | 1,416,287 | Mar 18 2009 | |||
| NORBY R DOUGLAS | Director | 11,089 | 1,416,287 | Jun 19 2009 | |||
| NORBY R DOUGLAS | Director | 11,089 | 1,416,287 | Aug 06 2009 | |||
| NORBY R DOUGLAS | Director | 27,628 | 3,528,648 | Oct 31 2011 | |||
| NORBY R DOUGLAS | Director | 2,000 | 255,440 | May 07 2007 | |||
| O'Neill Julie | EVP. Global Operations | 51,727 | 6,606,572 | Mar 02 2018 | |||
| ORLOFF JOHN J | EVP, Research & Development | 88,324 | 11,280,741 | Mar 02 2021 | |||
| PARVEN ALVIN S | Director | 7,568 | 966,585 | Jun 16 2017 | |||
| Reinsdorf Judith A | Director | 10,920 | 1,394,702 | May 18 2020 | |||
| ROLLINS SCOTT A | Sr. VP Drug Dev. & Proj. Man. | 3,100 | 395,932 | Jun 08 2005 | |||
| Rummelt Andreas | Director | 25,614 | 3,271,420 | May 18 2020 | |||
| SARIN ARADHANA | EVP, CFO | 63,940 | 8,166,417 | Mar 02 2021 | |||
| Sinha Vikas | EVP & CFO | 178,463 | 22,793,294 | Aug 10 2016 | |||
| Sinha Vikas | SVP & CFO | 86,480 | 11,045,226 | Apr 04 2011 | |||
| SQUINTO STEPHEN P | EVP, Chief Global Ops. Officer | 106,508 | 13,603,202 | Oct 28 2014 | |||
| Thiel Carsten | EVP, Chief Commercial Officer | 33,860 | 4,324,599 | Mar 06 2017 | |||
| Veneman Ann M | Director | 5,480 | 699,906 | Sep 05 2017 | |||
| Veneman Ann M | Director | 3,447 | 440,251 | Dec 15 2014 | |||
| Waeger Ruedi E | Director | 24,054 | 3,072,177 | May 05 2010 | |||
| Wagner Heidi L | SVP, Global Government Affairs | 49,594 | 6,334,146 | Mar 01 2018 | |||
| Wright Frank J | SVP, President Alxn Pharm Intl | 19,670 | 2,512,252 | Feb 10 2014 |